首页> 外文期刊>Medicine. >Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases
【24h】

Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases

机译:原发性胃淋巴瘤的临床特点和预后因素:165例回顾性研究

获取原文
           

摘要

Primary gastric lymphoma (PGL) is the most common extranodal non-Hodgkin lymphoma. This retrospective study aimed to analyze the clinical characteristics, prognostic factors, and roles of different treatment modalities in patients with PGL. From January 2003 to November 2014, 165 patients who were diagnosed with PGL at West China Hospital were enrolled in this study. The clinical features, treatment, and follow-up information were analyzed. In this study, diffuse large B-cell lymphoma (DLBCL) (108, 65.5%) and mucosa-associated lymphoid tissue (MALT) lymphoma (52, 31.5%) were two predominant histological subtypes. One-year and 5-year overall survival (OS) rates of all patients were 95.2% and 79.5%, respectively; in whom 110 (66.7%) underwent surgery, 110 (66.7%) received chemotherapy, 12 (7.3%) received radiotherapy, and 10 (6.1%) received Helicobacter pylori eradication. And 75 patients (45.5%) were treated with at least 2 different types of therapies. Elevated lactic dehydrogenase (LDH) levels, poor performance status (PS), advanced stage, International Prognostic Index (IPI) score ≥3, conservative treatment, and high-grade histological subtype were associated with worse prognosis in univariate analysis. Cox regression analysis showed that LDH levels, PS, staging, and histological subtype were independent predictors of survival outcomes. In the DLBCL type, 5-year OS was significantly better in the surgically treated group (80.1%) than that of patients conservatively treated (49.8%) (P?=?0.001). Surgical treatment had almost no impact on OS in the MALT type than conservative treatment (P?=?0.597). The proportion of patients received conservative treatment increased from 4.5% in period 1 to 51.7% in period 4. High LDH levels, poor PS, advanced staging, and malignant pathological type at diagnosis are significantly associated with poor OS. Our data suggest that surgery is superior in prognosis over conservative treatment in the DLBCL type, but not in the MALT type. Recently, conservative treatment is becoming more preferred approach in patients with PGL.
机译:原发性胃淋巴瘤(PGL)是最常见的结外非霍奇金淋巴瘤。这项回顾性研究旨在分析PGL患者的临床特征,预后因素以及不同治疗方式的作用。从2003年1月至2014年11月,本研究纳入了165名在华西医院诊断为PGL的患者。分析了临床特征,治疗和随访信息。在这项研究中,弥漫性大B细胞淋巴瘤(DLBCL)(108,65.5%)和黏膜相关淋巴样组织(MALT)淋巴瘤(52,31.5%)是两种主要的组织学亚型。所有患者的一年和五年总生存率分别为95.2%和79.5%。其中接受手术的110例(66.7%),接受化学疗法的110例(66.7%),接受放射疗法的12例(7.3%)和消灭幽门螺杆菌的10例(6.1%)。 75例患者(45.5%)接受了至少2种不同类型的治疗。乳酸脱氢酶(LDH)水平升高,表现状态(PS)差,晚期,国际预后指数(IPI)得分≥3,保守治疗和高级组织学亚型与单因素分析的预后差有关。 Cox回归分析表明,LDH水平,PS,分期和组织学亚型是生存结果的独立预测因子。在DLBCL型中,手术治疗组的5年OS明显好于保守治疗组的49.8%(80.1%)(P <0.001)。与保守治疗相比,手术治疗对MALT类型的OS几乎没有影响(P = 0.597)。接受保守治疗的患者比例从第1阶段的4.5%增加到第4阶段的51.7%。LDH水平高,PS差,分期晚期和诊断时的恶性病理类型与OS差显着相关。我们的数据表明,在DLBCL型中,手术的预后优于保守治疗,而在MALT型中则不然。最近,保守治疗正成为PGL患者的首选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号